Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
Conditions
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) · Liver Fibrosis/NASH · Non-Alcoholic Steato-Hepatitis (NASH)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Centre de recherche du CHUS, Sherbrooke, Quebec, Canada
Study leads
André Carpentier, MD
Principal Investigator
Université de Sherbrooke